Combination of Aspirin and Omeprazole for Colorectal Cancer Chemoprevention
$686,922N01FY2012CANIH
University Of Oklahoma Hlth Sciences Ctr, Oklahoma City OK
Investigators
Abstract
In terms of cost-effectiveness, taking low-dose aspirin daily is likely to be much more cos-effective than those interventions alredy used for preventing CRC, such as screening methods.
View original record on NIH RePORTER →